Results 111 to 120 of about 93,050 (197)

The protective effects of lipoxin A4 on type 2 diabetes mellitus: A Chinese prospective cohort study. [PDF]

Front Endocrinol (Lausanne), 2023
Wang S, Qian X, Shen C, Sun Q, Jing Y, Liu B, Zhang K, Li M, Wang J, Zhou H, Dong C.   +10 more
europepmc   +1 more source

Oxidoreductases in Lipoxin A4 Metabolic Inactivation [PDF]

Journal of Biological Chemistry, 2000
Clary B. Clish, Bruce D. Levy, Nan Chiang, Hsin-Hsiung Tai, Charles N. Serhan   +4 more
openaire   +1 more source

The role of leukotriene B4 and lipoxin A4 in the chronization of inflammation in lung tissue

, 2013
Anotācija Pētījuma mērķis bija noskaidrot arahidonskābes derivātu – lipoksīna A4 (LXA4) un leikotriēna B4 (LtB4)-, kā arī lipoksīna A4 receptora (ALXR) lomu hroniskas obstruktīvas plaušu slimības (HOPS) paasinājuma fāzes un pneimonijas patoģenēzē ...
Balode, Līga, Līga Balode
core  

Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease

, 2012
Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary ...
L Irving (12493954), P Wark (13346538), M Thompson (3257382), G Anderson (7719536), A S Merritt (13706950), J McQualter (13706947), M Uddin (9878309), B Levy (13333083), R Vlahos (9630134), S Bozinovski (9630131), Ana Hutchinson (13074054)   +10 more
core  

Intra-Airway Treatment with Synthetic Lipoxin A4 and Resolvin E2 Mitigates Neonatal Asthma Triggered by Maternal Exposure to Environmental Particles. [PDF]

Int J Mol Sci, 2023
Ramar M, Yano N, Fedulov AV.
europepmc   +1 more source

Lipoxin A4 attenuated dexamethasone-induced muscle atrophy via activation of PGC-1α/Nrf2/TFAM pathway. [PDF]

J Physiol Biochem, 2023
Rizk FH, Soliman NA, Kashef SM, Elsaadany AA.   +3 more
europepmc   +1 more source

Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney Disease. [PDF]

Diabetes
Bose M, Mohan M, Okabe J, Kaipananickal H, Priori V, Chhor C, Sourris KC, Radman R, Tikellis C, Zhang Y, El-Osta A, Brennan E, Guiry PJ, Gahan K, Tighe C, Thomas M, Jandeleit-Dahm K, Godson C, Kantharidis P, Cooper ME.   +19 more
europepmc   +1 more source

BML-111, the agonist of lipoxin A4, suppresses epithelial-mesenchymal transition and migration of MCF-7 cells via regulating the lipoxygenase pathway. [PDF]

Int J Immunopathol Pharmacol, 2023
Xu F, Zhou X, Lin L, Xu J, Feng Y, He Y, Hao H.   +6 more
europepmc   +1 more source

Lipoxin A4 Attenuates <i>E. coli</i>-Induced ARDS-Like Lung Injury in Mice via ALX/FPR2-Dependent Macrophage Reprogramming. [PDF]

J Inflamm Res
Zhang B, Xu M, Deng Y, Li D, Shen J, Pan C, He H.   +6 more
europepmc   +1 more source

Simvastatin Upregulates Lipoxin A4 and Accelerates Neuroinflammation Resolution After Intracerebral Hemorrhage. [PDF]

Curr Neurovasc Res, 2022
Zhang J, Hao N, Li W, Chen Q, Chen Z, Feng H, Wu Y, Shi X.   +7 more
europepmc   +1 more source